Literature DB >> 16131326

Regulation of type 1 iodothyronine deiodinase in health and disease.

Ronald J Koenig1.   

Abstract

The major physiologic function of type 1 iodothyronine deiodinase (D1) is to produce triiodothyronine (T(3)) for the plasma. D1 activity is regulated by numerous factors, perhaps the most important of which in human pathophysiology is T(3). T(3) induces D1 expression, contributing to the T(3) excess commonly found in hyperthyroidism. Cytokines, nutritional status, sex steroids, and other factors also regulate D1 activity, although different organs often show different responses. Numerous homeostatic mechanisms can counterbalance isolated changes in D1 expression, such as the genetically decreased expression in C3H/He mice. Two relatively commonly used drugs, propylthiouracil and amiodarone, inhibit D1, which can have substantial effects on circulating thyroid hormone levels. Overall, many factors interact in complex ways to establish D1 levels, contributing to the circulating concentrations of thyroxine (T(4)) and T(3).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16131326     DOI: 10.1089/thy.2005.15.835

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  19 in total

1.  Inhibition of the type 2 iodothyronine deiodinase underlies the elevated plasma TSH associated with amiodarone treatment.

Authors:  Matthew L Rosene; Gábor Wittmann; Rafael Arrojo e Drigo; Praful S Singru; Ronald M Lechan; Antonio C Bianco
Journal:  Endocrinology       Date:  2010-10-06       Impact factor: 4.736

Review 2.  Reawakened interest in type III iodothyronine deiodinase in critical illness and injury.

Authors:  Stephen A Huang; Antonio C Bianco
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-01-22

Review 3.  Deiodinases: implications of the local control of thyroid hormone action.

Authors:  Antonio C Bianco; Brian W Kim
Journal:  J Clin Invest       Date:  2006-10       Impact factor: 14.808

4.  Type 1 Deiodinase Regulates ApoA-I Gene Expression and ApoA-I Synthesis Independent of Thyroid Hormone Signaling.

Authors:  Jing Liu; Antonio Hernandez-Ono; Mark J Graham; Valerie Anne Galton; Henry N Ginsberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-05-05       Impact factor: 8.311

5.  Positive correlation between type 1 and 2 iodothyronine deiodinases activities in human goiters.

Authors:  Valmara S Pereira; Michelle P Marassi; Doris Rosenthal; Mário Vaisman; Vânia M Corrêa da Costa
Journal:  Endocrine       Date:  2011-12-30       Impact factor: 3.633

6.  Clinical and molecular characterization of a novel selenocysteine insertion sequence-binding protein 2 (SBP2) gene mutation (R128X).

Authors:  Caterina Di Cosmo; Neil McLellan; Xiao-Hui Liao; Kum Kum Khanna; Roy E Weiss; Laura Papp; Samuel Refetoff
Journal:  J Clin Endocrinol Metab       Date:  2009-07-14       Impact factor: 5.958

Review 7.  Effects of amiodarone therapy on thyroid function.

Authors:  Janna Cohen-Lehman; Peter Dahl; Sara Danzi; Irwin Klein
Journal:  Nat Rev Endocrinol       Date:  2010-01       Impact factor: 43.330

Review 8.  The syndromes of reduced sensitivity to thyroid hormone.

Authors:  Alexandra M Dumitrescu; Samuel Refetoff
Journal:  Biochim Biophys Acta       Date:  2012-08-16

Review 9.  Hyperthyroidism.

Authors:  Simone De Leo; Sun Y Lee; Lewis E Braverman
Journal:  Lancet       Date:  2016-03-30       Impact factor: 79.321

10.  Selenium and thyroid autoimmunity.

Authors:  Roberto Negro
Journal:  Biologics       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.